Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Serum markers of intrahepatic cholangiocarcinoma.

Malaguarnera G, Paladina I, Giordano M, Malaguarnera M, Bertino G, Berretta M.

Dis Markers. 2013;34(4):219-28. doi: 10.3233/DMA-130964. Review.

2.
3.

Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.

Kashihara T, Ohki A, Kobayashi T, Sato T, Nishizawa H, Ogawa K, Tako H, Kawakami F, Tsuji M, Tamaoka K.

J Gastroenterol. 1998 Jun;33(3):447-53.

PMID:
9658330
4.

Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.

Uenishi T, Yamazaki O, Tanaka H, Takemura S, Yamamoto T, Tanaka S, Nishiguchi S, Kubo S.

Ann Surg Oncol. 2008 Feb;15(2):583-9.

PMID:
17955299
5.

Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.

Leelawat K, Sakchinabut S, Narong S, Wannaprasert J.

BMC Gastroenterol. 2009 Apr 30;9:30. doi: 10.1186/1471-230X-9-30.

6.

Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.

Fujimoto K, Kawaguchi T, Nakashima O, Ono J, Ohta S, Kawaguchi A, Tonan T, Ohshima K, Yano H, Hayabuchi N, Izuhara K, Sata M.

Oncol Rep. 2011 May;25(5):1211-6. doi: 10.3892/or.2011.1194.

PMID:
21347516
7.

Serum and bile biomarkers for cholangiocarcinoma.

Alvaro D.

Curr Opin Gastroenterol. 2009 May;25(3):279-84. Review.

PMID:
19396965
8.

A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.

Sawanyawisuth K, Silsirivanit A, Kunlabut K, Tantapotinan N, Vaeteewoottacharn K, Wongkham S.

Parasitol Int. 2012 Mar;61(1):151-4. doi: 10.1016/j.parint.2011.07.013.

PMID:
21784171
9.

Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Tao LY, Cai L, He XD, Liu W, Qu Q.

Am Surg. 2010 Nov;76(11):1210-3.

PMID:
21140686
10.

Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.

Tolek A, Wongkham C, Proungvitaya S, Silsirivanit A, Roytrakul S, Khuntikeo N, Wongkham S.

Exp Biol Med (Maywood). 2012 Oct;237(10):1142-9. doi: 10.1258/ebm.2012.012215.

PMID:
23104505
11.
12.

Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.

Lempinen M, Isoniemi H, Mäkisalo H, Nordin A, Halme L, Arola J, Höckerstedt K, Stenman UH.

J Hepatol. 2007 Nov;47(5):677-83.

PMID:
17640760
13.

A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.

Hultcrantz R, Olsson R, Danielsson A, Järnerot G, Lööf L, Ryden BO, Wahren B, Broomé U.

J Hepatol. 1999 Apr;30(4):669-73.

PMID:
10207809
14.

Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.

Li YG, Zhang N.

Dig Liver Dis. 2009 Aug;41(8):605-8. doi: 10.1016/j.dld.2008.11.010.

PMID:
19168405
15.

Tumor markers as a diagnostic key for hilar cholangiocarcinoma.

Juntermanns B, Radunz S, Heuer M, Hertel S, Reis H, Neuhaus JP, Vernadakis S, Trarbach T, Paul A, Kaiser GM.

Eur J Med Res. 2010 Aug 20;15(8):357-61.

16.

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.

Uenishi T, Kubo S, Hirohashi K, Tanaka H, Shuto T, Yamamoto T, Nishiguchi S.

Br J Cancer. 2003 Jun 16;88(12):1894-9.

17.

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.

Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.

Eur J Surg Oncol. 2005 Mar;31(2):164-9.

PMID:
15698733
18.

Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Jesudian AB, Jacobson IM.

Rev Gastroenterol Disord. 2009 Spring;9(2):E41-7. Review.

PMID:
19668124
19.

A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma.

Silsirivanit A, Araki N, Wongkham C, Pairojkul C, Narimatsu Y, Kuwahara K, Narimatsu H, Wongkham S, Sakaguchi N.

Cancer. 2011 Aug 1;117(15):3393-403. doi: 10.1002/cncr.25912.

20.

Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.

Sriwanitchrak P, Viyanant V, Chaijaroenkul W, Srivatanakul P, Gram HR, Eursiddhichai V, Na-Bangchang K.

Asian Pac J Cancer Prev. 2011;12(6):1503-10.

Items per page

Supplemental Content

Support Center